Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02385708 · ClinicalTrials.gov registry record · NA
Use of 2% Chlorhexidine Cloths Reduce Surgical Site Infections
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 163
- Enrollment target
NCT02385708: Completed NA study, sponsored by Vanderbilt University.
NCT02385708 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 163 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02385708, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
Study Summary
Use of 2% chlorhexidine gluconate cloths pre-operatively and daily post-operatively jaw line to toes will decrease surgical site infections (SSI) by 30% when compared to patients who receive routine standard of care (use of chlorhexidine cloths night before surgery and morning of surgery).
Primary Outcome
Number of participants who had surgical site infection development at 30 day post operative visit based on Center for Disease Control Criteria for Defining A Surgical Site Infection (SSI), 2011.
Interventions
- DRUG 2% Chlorohexidine Gluconate Standard of Care
- DRUG 2% Chlorohexidine Gluconate Chin to Toe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-06-21 |
| Phase | NA |
What the finished NCT02385708 record still lists
NCT02385708 is an interventional study that assigns participants to a tested intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which 2% Chlorohexidine Gluconate Standard of Care is the first listed.
NCT02385708 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02385708 about?
NCT02385708 is a clinical study titled "Use of 2% Chlorhexidine Cloths Reduce Surgical Site Infections". Use of 2% chlorhexidine gluconate cloths pre-operatively and daily post-operatively jaw line to toes will decrease surgical site infections (SSI) by 30% when compared to patients who receive routine standard of care (use of chlorhexidine cloths night before surgery and morning of surgery).
What is the current status of trial NCT02385708?
This trial is currently completed. It is a NA study. The enrollment target is 163 participants. The study started on 2015-08. Estimated completion is 2018-06-21.
What interventions are being tested in trial NCT02385708?
The interventions under investigation include: 2% Chlorohexidine Gluconate Standard of Care (DRUG), 2% Chlorohexidine Gluconate Chin to Toe (DRUG).
Who is sponsoring clinical trial NCT02385708?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02385708's enrollment target sits among peer trials
163 627th of 2000 higher than 1,374 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia